154 related articles for article (PubMed ID: 25921687)
21. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
[TBL] [Abstract][Full Text] [Related]
22. High expression of stem cell marker ALDH1 is associated with reduced BRCA1 in invasive breast carcinomas.
Madjd Z; Ramezani B; Molanae S; Asadi-Lari M
Asian Pac J Cancer Prev; 2012; 13(6):2973-8. PubMed ID: 22938492
[TBL] [Abstract][Full Text] [Related]
23. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
[TBL] [Abstract][Full Text] [Related]
24. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of association of cancer stem cell marker aldehyde dehydrogenase 1 with clinicopathological profile in lung carcinoma patients.
Tiwari N; Srivastava AN; Tandon N; Lal N; Yadav S; Kant S; Jain M
Indian J Pathol Microbiol; 2018; 61(4):489-494. PubMed ID: 30303135
[TBL] [Abstract][Full Text] [Related]
26. ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer.
Avoranta ST; Korkeila EA; Ristamäki RH; Syrjänen KJ; Carpén OM; Pyrhönen SO; Sundström JT
Hum Pathol; 2013 Jun; 44(6):966-74. PubMed ID: 23332924
[TBL] [Abstract][Full Text] [Related]
27. Cancer stem cell marker ALDH1 expression is associated with lymph node metastasis and poor survival in esophageal squamous cell carcinoma: a study from high incidence area of northern China.
Wang Y; Zhe H; Gao P; Zhang N; Li G; Qin J
Dis Esophagus; 2012 Aug; 25(6):560-5. PubMed ID: 22098156
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.
Shien K; Toyooka S; Ichimura K; Soh J; Furukawa M; Maki Y; Muraoka T; Tanaka N; Ueno T; Asano H; Tsukuda K; Yamane M; Oto T; Kiura K; Miyoshi S
Lung Cancer; 2012 Jul; 77(1):162-7. PubMed ID: 22387005
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
[TBL] [Abstract][Full Text] [Related]
30. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
31. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer.
Goossens-Beumer IJ; Zeestraten EC; Benard A; Christen T; Reimers MS; Keijzer R; Sier CF; Liefers GJ; Morreau H; Putter H; Vahrmeijer AL; van de Velde CJ; Kuppen PJ
Br J Cancer; 2014 Jun; 110(12):2935-44. PubMed ID: 24786601
[TBL] [Abstract][Full Text] [Related]
32. Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer.
Li H; Ma F; Wang H; Lin C; Fan Y; Zhang X; Qian H; Xu B
Int J Biol Markers; 2013 Dec; 28(4):e357-64. PubMed ID: 24338721
[TBL] [Abstract][Full Text] [Related]
33. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
[TBL] [Abstract][Full Text] [Related]
34. Aldehyde dehydrogenase 1 (ALDH1) positivity correlates with poor prognosis in cervical cancer.
Yao T; Wu Z; Liu Y; Rao Q; Lin Z
J Int Med Res; 2014 Aug; 42(4):1038-42. PubMed ID: 24827824
[TBL] [Abstract][Full Text] [Related]
35. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
36. ALDH1 expression is correlated with pathologic grade and poor clinical outcome in patients with astrocytoma.
Liu DY; Ren CP; Yuan XR; Zhang LH; Liu J; Liu Q; Yuan J; Yuan D; Jiang XJ
J Clin Neurosci; 2012 Dec; 19(12):1700-5. PubMed ID: 23084350
[TBL] [Abstract][Full Text] [Related]
37. Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Kida K; Ishikawa T; Yamada A; Shimada K; Narui K; Sugae S; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Breast Cancer Res Treat; 2016 Apr; 156(2):261-9. PubMed ID: 26975188
[TBL] [Abstract][Full Text] [Related]
38. Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma.
Wu Q; Shi H; Holm R; Li X; Trope C; Nesland JM; Suo Z
Anticancer Res; 2014 Feb; 34(2):859-65. PubMed ID: 24511023
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of CD44v6, CD133, CD166, and ALDH1 Expression in Small Intestinal Adenocarcinoma.
Eom DW; Hong SM; Kim G; Bae YK; Jang KT; Yu E
Appl Immunohistochem Mol Morphol; 2015; 23(10):682-8. PubMed ID: 25710579
[TBL] [Abstract][Full Text] [Related]
40. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
Zenke Y; Ishii G; Ohe Y; Kaseda K; Yoshida T; Matsumoto S; Umemura S; Yoh K; Niho S; Goto K; Ohmatsu H; Kuwata T; Nagai K; Ochiai A
Pathol Int; 2013 Dec; 63(12):599-606. PubMed ID: 24422956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
